Association between health-related quality-of-life results, outcomes of efficacy and drug approvals: a meta-research study of randomized phase III trials in oncology

Autor: Paratore, C., Zichi, C., Schiavone, R., Caglio, A., Gamba, T., Bombaci, S., Vellani, G., Marandino, L., Perrone, F., Di Maio, M.

Publikováno v: In ESMO Open August 2024 9(8)

How to manage renal masses in kidney transplant recipients? A collaborative review by the EAU-YAU kidney transplantation and renal cancer working groups

Autor: Andras, I., Pecoraro, A., Telecan, T., Piana, A., Boissier, R., Hevia, V., Prudhomme, T., Amparore, D., Bertolo, R., Carbonara, U., Erdem, S., Diana, P., Ingels, A., Kara, O., Marandino, L., Marchioni, M., Muselaers, S., Pavan, N., Roussel, E., Crisan, N., Territo, A., Campi, R.

Publikováno v: In Actas Urológicas Españolas (English Edition) December 2023 47(10):621-630

Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After Platinum Chemotherapy: Safety and Preliminary Activity of the Open-Label, Single-Arm, Phase 2 ARCADIA Trial

Autor: Marandino, L, Raggi, D, Calareso, G, Alessi, A, Colecchia, M, Martini, A, Briganti, A, Montorsi, F, Madison, R, Ross, J S, Necchi, A

Publikováno v: In Clinical Genitourinary Cancer October 2021 19(5):457-465

Nectin-4 Positivity in Genitourinary Malignancies: A Systematic Review.

Autor: Crupi E; Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy., Costa de Padua T; Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy., Marandino L; Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy., Fallara G; Department of Urology, IRCCS Istituto Europeo di Oncologia, IEO, Milan, Italy., Pederzoli F; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY., Cimadamore A; Department of Medicine, Institute of Pathological Anatomy, University of Udine, Udine, Italy., Goetz EC; SDA Bocconi School of Management University, Milan, Italy., Cigliola A; Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy., Patané DA; Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy., Mercinelli C; Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy., Tateo V; Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy., Salonia A; Vita-Salute San Raffaele University, Milan, Italy.; Department of Urology, IRCCS San Raffaele Hospital, Milan, Italy., Briganti A; Vita-Salute San Raffaele University, Milan, Italy.; Department of Urology, IRCCS San Raffaele Hospital, Milan, Italy., Montorsi F; Vita-Salute San Raffaele University, Milan, Italy.; Department of Urology, IRCCS San Raffaele Hospital, Milan, Italy., Meeks JJ; Departments of Urology and Biochemistry, Molecular Genetics, Northwestern University, Feinberg School of Medicine, Chicago, IL., Spiess PE; Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, FL., Alhalabi O; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Gao J; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Kamat AM; Department of Urology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Grivas P; Department of Medicine, Division of Hematology Oncology, University of Washington, Seattle, WA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Necchi A; Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy., Raggi D; Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy.

Publikováno v: JCO precision oncology [JCO Precis Oncol] 2024 Dec; Vol. 8, pp. e2400470. Date of Electronic Publication: 2024 Dec 03.

Removing Barriers to the Use of Systemic Agents for Patients with von Hippel-Lindau Disease.

Autor: Larcher A; Department of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: larcher.alessandro@hsr.it., Belladelli F; Department of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy., Cei F; Department of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy., Re C; Department of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy., Rowe I; Department of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy., Salerno L; Department of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy., Marandino L; Department of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy., Raggi D; Department of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy., Necchi A; Department of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy., Capitanio U; Department of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy., Montorsi F; Department of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy., Salonia A; Department of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.

Publikováno v: European urology oncology [Eur Urol Oncol] 2024 Oct; Vol. 7 (5), pp. 1141-1143. Date of Electronic Publication: 2024 Jan 24.